KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$0.550
+0.0100 (+1.85%)
At Close: Apr 25, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.500 $0.720 Thursday, 25th Apr 2024 ADXS stock ended at $0.550. This is 1.85% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.550 to a day high of $0.550.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Mar 26, 2021 $0.778 $0.83 $0.743 $0.780 3 358 129
Mar 25, 2021 $0.729 $0.770 $0.703 $0.752 3 901 168
Mar 24, 2021 $0.80 $0.83 $0.755 $0.760 2 833 966
Mar 23, 2021 $0.84 $0.85 $0.785 $0.81 3 154 070
Mar 22, 2021 $0.87 $0.87 $0.83 $0.84 3 115 182
Mar 19, 2021 $0.84 $0.86 $0.81 $0.84 3 274 268
Mar 18, 2021 $0.87 $0.89 $0.82 $0.84 4 562 102
Mar 17, 2021 $0.83 $0.89 $0.82 $0.87 4 415 463
Mar 16, 2021 $0.95 $0.95 $0.81 $0.84 7 842 624
Mar 15, 2021 $0.94 $0.96 $0.90 $0.92 7 862 074
Mar 12, 2021 $0.82 $0.93 $0.80 $0.87 7 832 428
Mar 11, 2021 $0.81 $0.84 $0.793 $0.82 4 665 963
Mar 10, 2021 $0.85 $0.85 $0.762 $0.80 7 295 754
Mar 09, 2021 $0.700 $0.87 $0.692 $0.84 10 992 536
Mar 08, 2021 $0.710 $0.719 $0.660 $0.669 5 331 469
Mar 05, 2021 $0.730 $0.759 $0.575 $0.680 11 230 406
Mar 04, 2021 $0.710 $0.740 $0.625 $0.705 14 253 630
Mar 03, 2021 $0.83 $0.84 $0.745 $0.767 8 879 973
Mar 02, 2021 $0.88 $0.89 $0.82 $0.83 4 364 240
Mar 01, 2021 $0.89 $0.92 $0.87 $0.88 4 548 641
Feb 26, 2021 $0.88 $0.91 $0.82 $0.84 5 823 850
Feb 25, 2021 $1.01 $1.01 $0.87 $0.88 8 722 986
Feb 24, 2021 $0.91 $1.06 $0.91 $1.01 10 691 054
Feb 23, 2021 $0.96 $0.99 $0.690 $0.88 18 544 434
Feb 22, 2021 $1.18 $1.18 $1.07 $1.07 9 984 728
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT